Can We Reverse Aging?
Summary
Rachel Abrams interviews Susan Dominus about the booming field of longevity science, focusing on cellular rejuvenation techniques inspired by embryonic development. The episode explores controversial figures like David Sinclair and the massive funding from billionaires backing startups such as Altos Labs. It examines the potential for these therapies to treat age-related diseases, the ethical implications of extended lifespans, and whether scientific breakthroughs can offer accessible health benefits beyond lifestyle changes.
Topics discussed
Intro: Oli Probiotics ad and episode overview
Defining longevity science and cellular aging
Yamanaka factors and partial cellular reprogramming
David Sinclair's controversial research and claims
Ad break and Crossplay game segment
Billionaire funding and the Altos Labs initiative
Altos Labs' use of organoids and virtual cells
Realistic goals: Healthspan vs. extreme lifespan
Timeline for treatments and ethical concerns
Economic implications of extended human life
Lifestyle factors vs. technological shortcuts
Credits and closing ad
Listen ad-free on Castria